References
- Hashimoto K, Singer K, Lazarus GS, Penicillamine- induced pemphigus. Arch Dermatol (1984) 120: 762–4.
- Hirohata S, Nakanishi K, Yanagida T, Inhibition of cyclin A gene expression in human B cells by an immuno- suppressant mizoribine. Clin Exp Immunol (2000) 120: 448–53.
- Turka LA, Dayton J, Sinclair G et al, Guanine ribonucleo- tide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine. J Clin Invest (1991) 87: 940–8.
- Mitchell BS, Dayton JS, Turka LA et al, IMP dehydro- genase inhibitors as immunomodulators. Ann N Y Acad Sci (1993) 685: 217–24.
- Kono T, Terashima T, Oura H et al, Recalcitrant sub- corneal pustular dermatosis and bullous pemphigoid treated with mizoribine, and immunosuppressive, purine biosynthesis inhibitor. Br J Dermatol (2000) 143: 1328–30.
- Amagai M, Komai A, Hashimoto T et al, Usefulness of enzyme- linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis. Br J Dermatol (1999) 140: 351–7.
- Ogata K, Nakajima H, Ikeda M et al, Drug-induced pemphigus foliaceus with features of pemphigus vulgaris. Br J Dermatol (2001) 2: 421–2.
- Shapiro M, Jimenez S, Werth VP, Pemphigus vulgaris induced by D-penicillamine therapy in a patient with systemic sclerosis. J Am Acad Dermatol (2000) 42: 297–9.
- Ioannides D, Chrysomallis F, Bystryn JC, Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus. Arch Dermatol (2000) 136: 868–72.